Emerging Roles of YES1 in Cancer: The Putative Target in Drug Resistance

Emerging Roles of YES1 in Cancer: The Putative Target in Drug Resistance

Src family kinases (SFKs) are non-receptor tyrosine kinases that are recognized as proto-oncogenic products. Among SFKs, YES1 is frequently amplified and overexpressed in a variety of human tumors, including lung, breast, ovarian, and skin cancers. YES1 plays a pivotal role in promoting cell prolife...

Full description

Bibliographic Details
Main Authors: Eunjin Kook, Kyung-Soo Chun, Do-Hee Kim
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:International Journal of Molecular Sciences
Subjects:
Src family kinase
YES1
drug-resistance
cancer progression
Online Access:https://www.mdpi.com/1422-0067/25/3/1450

Similar Items

Similar Items